General Information

    • DRAMP ID

    • DRAMP18134

    • Peptide Name

    • Peptide Ctri9677

    • Source

    • Chaerilus tricostatus (Scorpion)

    • Family

    • Not found

    • Gene

    • Not found

    • Sequence

    • INWDILIDTIKDKL

    • Sequence Length

    • 14

    • Protein Existence

    • Transcript level

Activity Information

    • Biological Activity

    • Antimicrobial, Antiviral

    • Target Organism

    • No MICs found in DRAMP database

    • Hemolytic Activity

      • No hemolysis information or data found in the reference(s) presented in this entry

    • Cytotoxicity

      • Not included yet

    • Binding Target

    • Not found

Structure Information

    • Linear/Cyclic

    • Not included yet

    • N-terminal Modification

    • Not included yet

    • C-terminal Modification

    • Not included yet

    • Nonterminal Modifications and Unusual Amino Acids

    • Not included yet

    • Stereochemistry

    • Not included yet

    • Structure

    • Not found

    • Structure Description

    • Not found

    • Helical Wheel Diagram

    • DRAMP18134 helical wheel diagram

    • PDB ID

    • None

    • Predicted Structure

    • There is no predicted structure for DRAMP18134.

Physicochemical Information

    • Formula

    • C350H542N82O101S

    • Absent Amino Acids

    • CHP

    • Common Amino Acids

    • ILDF

    • Mass

    • 1700.01

    • PI

    • 4.43

    • Basic Residues

    • 8

    • Acidic Residues

    • 12

    • Hydrophobic Residues

    • 30

    • Net Charge

    • -4

    • Boman Index

    • -8926

    • Hydrophobicity

    • 0.034

    • Aliphatic Index

    • 109.84

    • Half Life

      • Mammalian:30 hour
      • Yeast:>20 hour
      • E.coli:>10 hour

    • Extinction Coefficient Cystines

    • 6990

    • Absorbance 280nm

    • 110.95

    • Polar Residues

    • 12

DRAMP18134

Comments Information

    • Function

    • Antimicrobial peptide (By similarity).##Miscellaneous

Literature Information

  • ·Literature 1

    • Title

    • Design of histidine-rich peptides with enhanced bioavailability andinhibitory activity against hepatitis C viruS.

    • Reference

    • Biomaterials 34:3511-3522 (2013).

    • Author

    • Hong W., Zhang R., Di Z., He Y., Zhao Z., Hu J., Wu Y., Li W., Cao Z.